New asthma drug passes early safety check in small trial
NCT ID NCT06947408
First seen Jun 09, 2026 · Last updated Jun 18, 2026 · Updated 3 times
Summary
This early-stage study tested an experimental drug called IBI3002 in 44 people to see if it is safe. It included both healthy volunteers and people with asthma. Participants received either the drug or a placebo, and researchers monitored for side effects. The goal was to find safe doses for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
China-japan Friendship Hosipital
Beijing, Beijing Municipality, 100192, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.